Category Industry Updates

Bristol Myers Squibb

Bristol Myers Squibb Highlights New ASCO® 2026 Findings Across Oncology Portfolio and Emerging Pipeline

Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline Bristol Myers Squibb announced the presentation of data from its oncology portfolio and pipeline at the 2026 American Society…

Read MoreBristol Myers Squibb Highlights New ASCO® 2026 Findings Across Oncology Portfolio and Emerging Pipeline
Sustained Therapeutics

Sustained Therapeutics Announces Positive Phase 2 ST-01 Data in Podium Presentation at AUA 2026 Annual Meeting

Sustained Therapeutics Presents Positive Phase 2 Data for ST-01 in Podium Presentation at the American Urological Association 2026 Annual Meeting Sustained Therapeutics, Inc. a clinical-stage urologic therapeutics company advancing differentiated therapies for underserved conditions, today presented additional data from its…

Read MoreSustained Therapeutics Announces Positive Phase 2 ST-01 Data in Podium Presentation at AUA 2026 Annual Meeting
Turn Therapeutics Appoints Former FDA

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical and Regulatory Lead

Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead Turn Therapeutics Inc. a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, announced the appointment of Stephen M. Hahn,…

Read MoreTurn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical and Regulatory Lead
ImmunityBio

ImmunityBio Secures Exclusive U.S. Deal with Japan BCG Laboratory to Expand Tokyo Strain BCG Supply

ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States ImmunityBio, Inc. a commercial-stage immunotherapy company, announced an exclusive U.S. Development and Supply Agreement with Japan BCG…

Read MoreImmunityBio Secures Exclusive U.S. Deal with Japan BCG Laboratory to Expand Tokyo Strain BCG Supply

OBIO® and IPON Renew Multi-Year Partnership to Strengthen Ontario’s Sovereign IP Capacity

OBIO® and IPON Renew Multi-Year Collaboration to Advance Ontario’s Sovereign IP Capacity OBIO® and Intellectual Property Ontario (IPON) have renewed their memorandum of understanding (MOU) to ensure that Ontario’s next generation of companies developing innovative human health products continue to access optimal…

Read MoreOBIO® and IPON Renew Multi-Year Partnership to Strengthen Ontario’s Sovereign IP Capacity
Transition

Transition Industries and National Forestry Commission Sign Wetlands Conservation Partnership in Sinaloa

Transition Industries and the Mexican Forestry Commission (CONAFOR) Sign Collaboration Agreement for Wetlands Conservation in Sinaloa Transition Industries LLC, developer of the Pacifico Mexinol project, and Mexico’s National Forestry Commission (Comisión Nacional Forestal, CONAFOR) signed a collaboration agreement to implement an Environmental…

Read MoreTransition Industries and National Forestry Commission Sign Wetlands Conservation Partnership in Sinaloa
GE HealthCare

GE HealthCare’s Next-Gen SIGNA MR Technology Accelerates Research and Clinical Innovation

GE HealthCare’s next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting,GE HealthCare’s announced advancements…

Read MoreGE HealthCare’s Next-Gen SIGNA MR Technology Accelerates Research and Clinical Innovation
low grade

Low-Grade Serous Ovarian Cancer Resource Guide Launches on World Ovarian Cancer Day to Support Patients and Caregivers

On World Ovarian Cancer Day, LGSOC Resource Guide Launches to Support People Living with Low-Grade Serous Ovarian Cancer STAAR Low-Grade Serous Ovarian Cancer Foundation, Not These Ovaries, and Verastem Oncology announced the launch of the LGSOC Resource Guide, a unique resource…

Read MoreLow-Grade Serous Ovarian Cancer Resource Guide Launches on World Ovarian Cancer Day to Support Patients and Caregivers
Travere

Sequenex partners with MedTech Innovator, a leading healthcare startup accelerator

Sequenex Announces Partnership with MedTech Innovator, Industry’s Leading Startup Accelerator Sequenex announced its partnership with MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies. MedTech Innovator matches healthcare industry leaders with innovative early-stage medtech companies for mentorship and…

Read MoreSequenex partners with MedTech Innovator, a leading healthcare startup accelerator
Cleaner by Design

Cleaner by Design: SaniSure Launches PETG PharmaTainer™ Ultra-Clean Bottles and Carboys

Cleaner by Design: SaniSure Introduces PETG PharmaTainer™ Ultra-Clean Bottles & Carboys SaniSure® announced the launch of PETG PharmaTainer™, a new line of bioprocessing bottles and carboys combining widely accepted, medical-grade Eastman Eastar® PETG 6763 resin (DMF#9987) with SaniSure’s proprietary process…

Read MoreCleaner by Design: SaniSure Launches PETG PharmaTainer™ Ultra-Clean Bottles and Carboys
AMGTA

AMGTA report highlights additive manufacturing role in resource-efficient systems

AMGTA Releases Independent Report on Additive Manufacturing’s Role in Resource-Efficient Manufacturing Systems Following its 2026 Annual Member Summit, AMGTA released Additive Manufacturing in Resource-Efficient Manufacturing Systems, an independent report establishing how additive manufacturing should be evaluated, communicated, and deployed across part,…

Read MoreAMGTA report highlights additive manufacturing role in resource-efficient systems